It’s been 20 years since the Human Genome Project published its first blueprint of human gene sequences, starting a new era of medical research, but now scientists have go
Contract research organisation (CRO) Syneos Health has agreed to be acquired by a group of investors, in the second multibillion-dollar takeover of a pharma outsourcing bu
Boehringer Ingelheim and partner Zealand Pharma have reported new clinical data in obesity for their dual glucagon/GLP1 agonist BI 456906, setting up a possible challenge
Gilead Sciences has bulked up its early-stage R&D portfolio with an agreement to buy XinThera, adding drugs targeting PARP for oncology and MK2 for inflammatory diseas
Baxter has reached an agreement to sell its contract development and manufacturing organisation (CDMO) business to a pair of private equity companies, raising $4.25 billio